SEC Form 4 · accession 0001562180-18-002193
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick J Zenner
Director
Period of report
May 1, 2018
Accepted (ET)
May 3, 2018 · 5:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 1, 2018 | A | 1,824 | $0.00 | A | 55,681 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares of restricted stock units will vest in full on the first anniversay of the date of grant and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.
- F2Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.